HH-120 clinical trials
Also written HH-120.
How each study uses HH-120 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2022 (5)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 3
Huahui Health (5) · Beijing Ditan Hospital (3)
Studies
Open first, then newest update. How each study uses HH-120 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2CompletedPhase 3Huahui HealthNCT05787418Written as HH-120 Nasal SprayHow we know
- A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19CompletedPhase 2Huahui HealthNCT05713318Written as HH-120 nasal sprayHow we know
- A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 PatientsCompletedNot applicableBeijing Ditan HospitalNCT05659602Written as HH-120 Nasal SprayHow we know
- A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy VolunteersCompletedPhase 1Huahui HealthNCT05753878Written as HH-120 nasal spray, PartA cohort 1How we know
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy VolunteersCompletedPhase 1Huahui HealthNCT05116865Written as HH-120 Dose 1How we know
- A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19CompletedPhase 1Huahui HealthNCT06039163Written as HH-120How we know
- A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2CompletedNot applicableBeijing Ditan HospitalNCT05765279Written as HH-120 nasal spray 1How we know
- A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19CompletedNot applicableBeijing Ditan HospitalNCT05747677Written as HH-120 Nasal SprayHow we know